)
)
)
Crank Bio, Inc
Crank Bio is advancing a new class of RNA antisense-based therapies called small nuclear guide RNAs (SNuG-RNAs) designed to overcome the current limitations of antisense oligonucleotide (ASO) therapies to treat a wide range of serious human genetic diseases.
Crank Bio is initially focused on ophthalmic and hearing genetic diseases and is currently advancing a treatment for Usher's syndrome type 2 (USH2A).
Address
Ann ArborMichigan
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)